Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Cyclophosphamide Toxicity”

29 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 29 results

Testing effectiveness (Phase 2)Ended earlyNCT04896658
What this trial is testing

Belantamab Mafodotin, Cyclophosphamide, and Dexamethasone in Relapsed/Refractory Multiple Myeloma

Who this might be right for
Relapsed/Refractory Multiple Myeloma
University of Maryland, Baltimore 10
Not applicableStudy completedNCT00001473
What this trial is testing

Cyclophosphamide and Prednisone Followed by Methotrexate To Treat Vasculitides

Who this might be right for
VasculitisWegener's Granulomatosis
National Institute of Allergy and Infectious Diseases (NIAID) 100
Post-approval studies (Phase 4)Study completedNCT01124526
What this trial is testing

Efficacy Response Duration and Toxicity of Rituximab, Fludarabine, and Cyclophosphamide (RFC) as 1st Line Treatment and Rituximab (R) in Maintenance Treatment in Follicular Non Hodgkin (FNH) Lymphoma

Who this might be right for
Non Hodgkin Lymphoma
Asociacion Espanola de Hematologia y Hemoterapia 75
Not applicableLooking for participantsNCT03555851
What this trial is testing

Factors Affecting Post-transplant Cyclophosphamide (PTCy) Efficacy

Who this might be right for
Leukemia, Not Otherwise SpecifiedLeukemia, Other
Wake Forest University Health Sciences 120
Post-approval studies (Phase 4)UnknownNCT05302336
What this trial is testing

AC vs TC in Patients With HR-positive, HER2-negative Early Breast Cancer

Who this might be right for
Breast CancerChemotherapeutic Toxicity
Second Affiliated Hospital, School of Medicine, Zhejiang University 402
Not applicableUnknownNCT04581967
What this trial is testing

Study of CYP2C19 and ALDH3A1 Polymorphisms in Breast Cancer Patients

Who this might be right for
Breast Cancer Patients
Damanhour University 100
Large-scale testing (Phase 3)Study completedNCT02214381
What this trial is testing

A Prospective, Multicenter, Open-label 12 Week Neoadjuvant Phase II Trial Optimizing Taxane Therapy in Elderly Patients With Low Response

Who this might be right for
Early Primary Breast Cancer
West German Study Group 80
Testing effectiveness (Phase 2)Study completedNCT00436566
What this trial is testing

Doxorubicin and Cyclophosphamide Followed By Trastuzumab, Paclitaxel, and Lapatinib in Treating Patients With Early-Stage HER2-Positive Breast Cancer That Has Been Removed By Surgery

Who this might be right for
Breast CancerCardiac Toxicity
Mayo Clinic 122
Testing effectiveness (Phase 2)Study completedNCT00003068
What this trial is testing

High-Dose Chemotherapy and Autologous Blood Cell Transplantation in Treating Patients With Primary, Locally Advanced, or Stage IV Breast Cancer

Who this might be right for
Breast CancerDrug/Agent Toxicity by Tissue/Organ
University of Arizona 30
Early research (Phase 1)Study completedNCT00001676
What this trial is testing

Cyclophosphamide and Fludarabine to Treat Lupus Nephritis

Who this might be right for
GlomerulonephritisLupus NephritisSystemic Lupus Erythematosus
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) 15
Not applicableStudy completedNCT03339804
What this trial is testing

Neurovascular Changes Induced by Chemotherapy

Who this might be right for
Breast CancerChemotherapeutic Toxicity
University of Sao Paulo General Hospital 16
Testing effectiveness (Phase 2)Study completedNCT00003269
What this trial is testing

Amifostine Followed by High Dose Chemotherapy in Treating Patients With Hematologic Cancer or Solid Tumors

Who this might be right for
Breast CancerDrug/Agent Toxicity by Tissue/OrganLung Cancer+3 more
Scripps Health 20
Not applicableStudy completedNCT01779882
What this trial is testing

Cyclophosphamide and Busulfan as Conditioning Regimen Before Allogeneic HSCT

Who this might be right for
Myeloid LeukemiaPrecursor Myeloid NeoplasmsLymphoid Neoplasms
University Hospital, Basel, Switzerland 72
Not applicableEnded earlyNCT00352872
What this trial is testing

Pharmacogenetics as a Predictor of Toxicity in Pre-Menopausal Women Receiving Doxorubicin and Cyclophosphamide in Early Breast Cancer

Who this might be right for
Breast Cancer
Indiana University School of Medicine 23
Testing effectiveness (Phase 2)Study completedNCT00727441
What this trial is testing

Vaccine Therapy With or Without Cyclophosphamide in Treating Patients Undergoing Chemotherapy and Radiation Therapy for Stage I or Stage II Pancreatic Cancer That Can Be Removed by Surgery

Who this might be right for
Pancreatic Cancer
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 87
Testing effectiveness (Phase 2)Study completedNCT00941720
What this trial is testing

Busulfan, Cyclophosphamide, and Autologous Stem Cell Transplant in Treating Patients With Multiple Myeloma

Who this might be right for
Multiple Myeloma and Plasma Cell Neoplasm
Case Comprehensive Cancer Center 71
Testing effectiveness (Phase 2)UnknownNCT06176339
What this trial is testing

Assessing the Clinical Utility of Adding Pentoxifylline to Neoadjuvant Chemotherapy Protocols in Breast Cancer Patients"

Who this might be right for
Breast Cancer Female
Mansoura University 70
Early research (Phase 1)Study completedNCT01435499
What this trial is testing

Safety Study of a Melanoma Vaccine (GVAX) With or Without Cyclophosphamide in Patients With Surgically Resected Melanoma

Who this might be right for
Melanoma
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 21
Not applicableStudy completedNCT05886335
What this trial is testing

Influence of Timing PTCy in AlloSCT

Who this might be right for
Cyclophosphamide ToxicityAllogenic Haematopoetic Transplantation
Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau 180
Not applicableStudy completedNCT03908528
What this trial is testing

Alpha-Lipoic Acid in Breast Cancer Patients

Who this might be right for
Breast CancerChemotherapeutic Toxicity
Damanhour University 64
Load More Results